NasdaqCM - Nasdaq Real Time Price USD
INmune Bio, Inc. (INMB)
As of 11:24 AM EST. Market Open.
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-25,749.00
-11,980.00
-22,686.00
-28,504.00
-8,943.00
Investing Cash Flow
--
--
--
-15,000.00
--
Financing Cash Flow
17,789.00
-4,225.00
729.00
96,357.00
23,895.00
End Cash Position
33,853.00
35,848.00
52,153.00
74,810.00
21,967.00
Interest Paid Supplemental Data
1,045.00
1,778.00
1,372.00
559.00
--
Capital Expenditure
--
--
--
-15,000.00
--
Issuance of Capital Stock
27,789.00
775.00
699.00
80,253.00
24,907.00
Issuance of Debt
--
--
--
14,951.00
--
Repayment of Debt
-10,000.00
-5,000.00
--
--
--
Repurchase of Capital Stock
--
--
--
--
-1,012.00
Free Cash Flow
-25,749.00
-11,980.00
-22,686.00
-43,504.00
-8,943.00
12/31/2020 - 2/4/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
TFFP TFF Pharmaceuticals, Inc.
1.7000
+4.29%
COYA Coya Therapeutics, Inc.
7.35
+1.81%
ANIX Anixa Biosciences, Inc.
3.6350
+0.41%
ANVS Annovis Bio, Inc.
8.16
-5.23%
GANX Gain Therapeutics, Inc.
2.2400
+0.45%
IMUX Immunic, Inc.
1.1800
0.00%
VTGN Vistagen Therapeutics, Inc.
3.2100
+2.88%
INAB IN8bio, Inc.
0.3248
-1.75%
CUE Cue Biopharma, Inc.
1.8450
+3.65%
TERN Terns Pharmaceuticals, Inc.
7.12
+0.85%